MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Benitec Biopharma Limited (NASDAQ: BNTC)*
Organization & Developments: Benitec Biopharma
Parents
Benitec Biopharma Limited (NASDAQ: BNTC)*
Children
*Benitec Biopharma Ltd is an Australian biotechnology company
*It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
2024: Benitec Biopharma Reports Promising Results for BB-301 Trial_www.tipranks.com
2024: Benitec Biopharma: OPMD Program Continues To Advance With Catalysts
2024: Benitec Biopharma's BB-301: Potential In OPMD But Still Too Early Stages
2024: Benitec Biopharma’s Oculopharyngeal Muscular Dystrophy Gene Therapy Produces Clinical Improvements in Swallowing in Phase 1b/2a Trial
2025: Benitec Biopharma: Early Positive Data, Small Target Market, Little Competition_ seekingalpha.com
Jumps
Finance & Acquisitions: Benitec Biopharma
Key People: Benitec Biopharma